Allergy Therapeutics plc (AIM:AGY)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 4.635
+0.135 (2.99%)
Oct 21, 2026, 4:01 PM BST
Allergy Therapeutics Market Cap
Allergy Therapeutics has a market cap or net worth of 284.96 million as of October 21, 2026. It is the 16,552nd most valuable company in the world and the 357th biggest in the United Kingdom. Its market cap has decreased by 23.35% in one year.
Market Cap
284.96M
Enterprise Value
301.63M
Revenue
57.29M
Global Rank
Country Rank
#357 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since October 11, 2004, Allergy Therapeutics's market cap has increased from 30.57M to 284.96M, an increase of 832.18%. That is a compound annual growth rate of 10.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 284.96M | -57.82% |
| Dec 31, 2025 | 675.56M | 118.05% |
| Dec 31, 2024 | 309.82M | 160.00% |
| Dec 29, 2023 | 119.16M | 180.75% |
| Dec 30, 2022 | 42.44M | -79.49% |
| Dec 31, 2021 | 206.98M | 94.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Haleon | 32.82B |
| Hikma Pharmaceuticals | 3.49B |
| HUTCHMED (China) | 1.85B |
| ECO Animal Health Group | 64.71M |
| Shield Therapeutics | 60.98M |
| Provexis | 21.11M |
| Hellenic Dynamics | 1.32M |
| Chill Brands Group | 915.12K |